New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - flucloxacillin sodium monohydrate 1 g;   - powder for injection - 1 g - active: flucloxacillin sodium monohydrate 1 g   - latest regulatory activity

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - flucloxacillin sodium monohydrate 250mg;   - powder for injection - 250 mg - active: flucloxacillin sodium monohydrate 250mg  

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - flucloxacillin sodium monohydrate 500mg;   - powder for injection - 500 mg - active: flucloxacillin sodium monohydrate 500mg  

Australia - English - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - flucloxacillin sodium monohydrate, quantity: 563.78 mg - capsule - excipient ingredients: indigo carmine; titanium dioxide; methyl hydroxybenzoate; magnesium stearate; propyl hydroxybenzoate; gelatin; purified water; propylene glycol; butan-1-ol; isopropyl alcohol; shellac; ethanol absolute; ammonia; potassium hydroxide - treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections including pneumonia, osteomyelitis, skin and soft tissue and wound infections, infected burns, cellulitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - flucloxacillin sodium monohydrate, quantity: 281.89 mg - capsule - excipient ingredients: magnesium stearate; gelatin; indigo carmine; titanium dioxide; propyl hydroxybenzoate; methyl hydroxybenzoate; purified water; propylene glycol; butan-1-ol; isopropyl alcohol; shellac; ethanol absolute; ammonia; potassium hydroxide - treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections including pneumonia, osteomyelitis, skin and soft tissue and wound infections, infected burns, cellulitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - flucloxacillin sodium monohydrate, quantity: 281.89 mg - capsule - excipient ingredients: gelatin; indigo carmine; propyl hydroxybenzoate; methyl hydroxybenzoate; titanium dioxide; magnesium stearate; purified water; propylene glycol; butan-1-ol; isopropyl alcohol; shellac; ethanol absolute; ammonia; potassium hydroxide - treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections including pneumonia, osteomyelitis, skin and soft tissue and wound infections, infected burns, cellulitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - flucloxacillin sodium monohydrate, quantity: 563.78 mg - capsule - excipient ingredients: methyl hydroxybenzoate; magnesium stearate; propyl hydroxybenzoate; gelatin; titanium dioxide; indigo carmine; purified water; propylene glycol; butan-1-ol; isopropyl alcohol; shellac; ethanol absolute; ammonia; potassium hydroxide - treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections including pneumonia, osteomyelitis, skin and soft tissue and wound infections, infected burns, cellulitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - flucloxacillin sodium monohydrate, quantity: 563.78 mg - capsule - excipient ingredients: propyl hydroxybenzoate; titanium dioxide; methyl hydroxybenzoate; magnesium stearate; indigo carmine; gelatin; purified water; propylene glycol; butan-1-ol; isopropyl alcohol; shellac; ethanol absolute; ammonia; potassium hydroxide - treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections including pneumonia, osteomyelitis, skin and soft tissue and wound infections, infected burns, cellulitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - flucloxacillin sodium monohydrate, quantity: 281.89 mg - capsule - excipient ingredients: propyl hydroxybenzoate; indigo carmine; titanium dioxide; methyl hydroxybenzoate; gelatin; magnesium stearate; purified water; propylene glycol; butan-1-ol; isopropyl alcohol; shellac; ethanol absolute; ammonia; potassium hydroxide - treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections including pneumonia, osteomyelitis, skin and soft tissue and wound infections, infected burns, cellulitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - flucloxacillin sodium monohydrate, quantity: 281.89 mg - capsule - excipient ingredients: methyl hydroxybenzoate; titanium dioxide; gelatin; magnesium stearate; propyl hydroxybenzoate; indigo carmine; purified water; propylene glycol; butan-1-ol; isopropyl alcohol; shellac; ethanol absolute; ammonia; potassium hydroxide - treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections including pneumonia, osteomyelitis, skin and soft tissue and wound infections, infected burns, cellulitis.